Sanctuary Advisors, LLC Ascendis Pharma A/S Transaction History
Sanctuary Advisors, LLC
- $15.8 Trillion
- Q4 2024
A detailed history of Sanctuary Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 1,597 shares of ASND stock, worth $193,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,597Holding current value
$193,029% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
240Shares Held
58.2MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.17 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$621 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$603 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$533 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$506 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.75B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...